Schafer has named Nvidia and three other stocks as Oppenheimer's top stock picks for 2025. Nvidia is "the largest volume ...

Oppenheimer analysts maintained their Outperform rating and $83.00 price target for Aptive PLC (NYSE:APTV). The decision ...

R Madhavan about his working philosophies, his disappointment with recent Hollywood films including Christopher Nolan’s ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising ...

Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...

Robert Downey Jr reached the pinnacle of his career when he worked with Christopher Nolan, which doesn't mean he's obligated to be a fanboy.

Oppenheimer analysts updated their “buy” and “sell” recommendations within each of the 11 sectors among small- and mid-caps.

Hamilton Lane (HLNE) shares advanced 2.6% in Tuesday morning trading after Oppenheimer analyst Chris Kotowski upgraded the ...

Tom Holland is set to play the lead role in Christopher Nolan ‘s next film, which is set to be an epic adaptation of the ancient Greek poem The Odyssey. One of the oldest works of literature that is ...

However, in the past six months Elbit's share price has gained upward momentum. Since the end of June the company's share ...